Lead Business Planning & Analysis
Novartis
Lead Business Planning & Analysis
Novartis
Global pharmaceutical company delivering science-based innovations
Job Description Summary
#LI-HybridJob Description
Key Responsibilities
Essential Requirements
Commitment to Diversity and Inclusion
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and accommodation
Novartis is committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to perform the essential functions of a position, please send an e-mail to [email protected] and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Skills Desired
Artificial Intelligence (AI), Building High Performance Team, Capital Allocation, Critical Thinking, Database Normalization, Data Cleansing, Data Visualization, Financial Management Reporting, Give Feedback, Insight Generation, Interpersonal Relationships, Key Driver Analysis (KDA), Managing Ambiguity, Market Understanding, Planning Analysis, Post-Merger Integrations (PMI), Problem Solving, Process Optimization, Stakeholder InfluenceNovartis is a global pharmaceutical company that uses science-based innovations to develop treatments and improve patient outcomes worldwide. Its products are medicines developed through research and development to address various diseases, aiming to reach nearly 1 billion people. The company differentiates itself by large-scale investment in R&D, a global presence with a diverse workforce, and a clear mission to Reimagine Medicine, focusing on meeting the changing needs of patients. Its goal is to improve quality of life and extend life expectancy by delivering meaningful therapies through its research and development efforts.
Explore more opportunities at Novartis